Availability, stock levels and usage of In-vitro diagnostics in the Bono region, Ghana: A cross-sectional study.
Bono Region
POC diagnostic testing
accessibility
funding
stock level
Journal
African journal of primary health care & family medicine
ISSN: 2071-2936
Titre abrégé: Afr J Prim Health Care Fam Med
Pays: South Africa
ID NLM: 101520860
Informations de publication
Date de publication:
23 Oct 2023
23 Oct 2023
Historique:
received:
03
04
2023
accepted:
28
07
2023
revised:
21
07
2023
medline:
3
11
2023
pubmed:
2
11
2023
entrez:
2
11
2023
Statut:
epublish
Résumé
Point-of-care (POC) diagnostic tests play essential roles in diagnosis, surveillance, and disease management in health settings. Nevertheless, implementation challenges may hamper POC test accessibility. This study evaluated the availability and stock levels of the World Health Organization (WHO) prequalified existing in-vitro diagnostics (IVDs) for use in health facilities without laboratories. To evaluate the availability, stock levels, and usage of POC diagnostic tests. Bono Region, Ghana. This cross-sectional survey involved 102 randomly selected Community Health-based and Planning Services (CHPS), 12 district health depots, and a regional medical depot. Using a survey tool, data were collected on clinic staffing, availability and stock levels of tests, and funding sources. STATA 17 was employed for data analysis. Majority (37.3%) of the respondents were community health nurses, with 4.4 mean years of work experience and 38 working hours per week. Of the 18 existing WHO prequalified POC tests for use at facilities without laboratories, 10 (56%), 2 (11%) and 0 (0%) were found at CHPS, regional, and district depots, respectively. Majority (183 out of 301) stock levels were low. Of the 10 available tests found, 7 scored 111 (36%) of 'high use'. Supply chain management compliance was 5 (31%) out of 16. All CHPS received government funding with 25.5% of them receiving additional donor or internally generated funding. This study found poor supply chain management compliance, and low availability of POC tests in the Bono Region of Ghana.Contribution: The study outlines POC tests availability and usage in low-resourced setting.
Sections du résumé
BACKGROUND
BACKGROUND
Point-of-care (POC) diagnostic tests play essential roles in diagnosis, surveillance, and disease management in health settings. Nevertheless, implementation challenges may hamper POC test accessibility. This study evaluated the availability and stock levels of the World Health Organization (WHO) prequalified existing in-vitro diagnostics (IVDs) for use in health facilities without laboratories.
AIM
OBJECTIVE
To evaluate the availability, stock levels, and usage of POC diagnostic tests.
SETTING
METHODS
Bono Region, Ghana.
METHODS
METHODS
This cross-sectional survey involved 102 randomly selected Community Health-based and Planning Services (CHPS), 12 district health depots, and a regional medical depot. Using a survey tool, data were collected on clinic staffing, availability and stock levels of tests, and funding sources. STATA 17 was employed for data analysis.
RESULTS
RESULTS
Majority (37.3%) of the respondents were community health nurses, with 4.4 mean years of work experience and 38 working hours per week. Of the 18 existing WHO prequalified POC tests for use at facilities without laboratories, 10 (56%), 2 (11%) and 0 (0%) were found at CHPS, regional, and district depots, respectively. Majority (183 out of 301) stock levels were low. Of the 10 available tests found, 7 scored 111 (36%) of 'high use'. Supply chain management compliance was 5 (31%) out of 16. All CHPS received government funding with 25.5% of them receiving additional donor or internally generated funding.
CONCLUSION
CONCLUSIONS
This study found poor supply chain management compliance, and low availability of POC tests in the Bono Region of Ghana.Contribution: The study outlines POC tests availability and usage in low-resourced setting.
Identifiants
pubmed: 37916723
doi: 10.4102/phcfm.v15i1.4114
pmc: PMC10623501
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1-e10Références
Sex Transm Infect. 2017 Dec;93(S4):S1-S2
pubmed: 29223958
Heliyon. 2019 Feb 19;5(2):e01236
pubmed: 30828664
Diabet Med. 2019 May;36(5):626-632
pubmed: 30710457
Diagnostics (Basel). 2022 Mar 15;12(3):
pubmed: 35328268
PLoS One. 2021 Feb 17;16(2):e0246876
pubmed: 33596241
Anal Chem. 2012 Jan 17;84(2):487-515
pubmed: 22221172
Matern Health Neonatol Perinatol. 2015 Mar 18;1:7
pubmed: 27057324
Diagnostics (Basel). 2017 Nov 29;7(4):
pubmed: 29186013
Expert Rev Mol Diagn. 2016;16(4):449-59
pubmed: 26777725
J Appl Lab Med. 2021 Jan 12;6(1):51-62
pubmed: 33438734
Foot Ankle Int. 2018 Mar;39(3):387
pubmed: 29406785
Arch Pathol Lab Med. 2020 Nov 1;144(11):1372-1380
pubmed: 33106858
RSC Adv. 2018 Oct 3;8(59):34012-34034
pubmed: 35548839
Nat Rev Microbiol. 2021 Mar;19(3):171-183
pubmed: 33057203
BMC Public Health. 2016 Sep 08;16:951
pubmed: 27609056
Diagnostics (Basel). 2019 Nov 05;9(4):
pubmed: 31694228
BMJ. 2015 Mar 04;350:h1019
pubmed: 25739769
BMC Pregnancy Childbirth. 2020 Nov 25;20(1):733
pubmed: 33238918
BMC Pregnancy Childbirth. 2016 Jun 02;16(1):132
pubmed: 27255155
BMC Infect Dis. 2022 Jun 20;22(1):561
pubmed: 35725437
PLoS One. 2018 Sep 7;13(9):e0203524
pubmed: 30192839
Hum Resour Health. 2021 Mar 31;19(1):43
pubmed: 33789670
Annu Rev Biomed Eng. 2008;10:107-44
pubmed: 18358075
PLoS One. 2019 Feb 27;14(2):e0211498
pubmed: 30811407
PLoS Med. 2012;9(9):e1001306
pubmed: 22973183
Malar J. 2016 Feb 27;15:126
pubmed: 26921263
BMC Pregnancy Childbirth. 2017 May 31;17(1):159
pubmed: 28566088
BMC Health Serv Res. 2020 May 19;20(1):444
pubmed: 32429903
Int J Gynaecol Obstet. 2015 Jun;130 Suppl 1:S63-9
pubmed: 25980367
Am J Hum Biol. 2022 Nov;34(11):e23808
pubmed: 36166487
BMC Health Serv Res. 2018 Feb 20;18(1):130
pubmed: 29458363
Diagnostics (Basel). 2017 Jan 08;7(1):
pubmed: 28075337
BMC Health Serv Res. 2019 Jul 24;19(1):519
pubmed: 31340833
Bioeng Transl Med. 2020 Aug 13;5(3):e10177
pubmed: 32838038
Biosensors (Basel). 2017 Dec 18;7(4):
pubmed: 29258285
Int J Cardiol. 2015 Nov 1;198:26-30
pubmed: 26149334
Br J Haematol. 2021 Jun;193(5):894-901
pubmed: 33993492
Clin Infect Dis. 2016 Feb 1;62(3):369-374
pubmed: 26423384
Glob Health Sci Pract. 2020 Oct 2;8(3):549-565
pubmed: 33008863
J Glob Health. 2016 Jun;6(1):010304
pubmed: 26955469